Date December. 27, 2005
Source: Newsday
Summary:
Scientists at Memorial Sloan-Kettering Cancer Center in Manhattan have developed a stem cell-based gene therapy that targets stem cells and restores effective oxygen delivery, which may cure two pervasive blood disorders. The first round of human trials is expected to begin within six months. Gene therapy is the technique in which a healthy new gene is incorporated into patients' cells to correct a debilitating defect. Scientists report that they have developed a form of gene therapy that targets stem cells and restores effective oxygen delivery.
